(Total Views: 263)
Posted On: 05/27/2022 2:02:43 PM
Post# of 1418
Lots of great info.
Over 1.9 B for only 2 of the 3 assets 3CL Pharma has.
What I liked to see that didn't know was
"We have now gained insights that we wish to share with customers that will drive our future packaging decisions, dosing recommendations and marketing plans as we continue to do research with Long COVID clinics to better understand how customers can get the most out of Tollovid."
Business with LC Clinics.
That's going to be a worthwhile endeavor, especially seeing what the CDC said and what we're seeing worldwide.
Good update and looking forward to seeing what's going to be revealed June 30th and what could be unfolding by the conference.
Over 1.9 B for only 2 of the 3 assets 3CL Pharma has.
What I liked to see that didn't know was
"We have now gained insights that we wish to share with customers that will drive our future packaging decisions, dosing recommendations and marketing plans as we continue to do research with Long COVID clinics to better understand how customers can get the most out of Tollovid."
Business with LC Clinics.
That's going to be a worthwhile endeavor, especially seeing what the CDC said and what we're seeing worldwide.
Good update and looking forward to seeing what's going to be revealed June 30th and what could be unfolding by the conference.
(1)
(0)
